Intrepid Potash, MasterCard see analyst action Thursday

Intrepid Potash and MasterCard were among the stocks seeing analyst rating action Thursday according to theflyonthewall.com.

Goldman Sachs’ analysts reiterated their sell rating on Intrepid IPI, noting the company missed on its latest earnings because of weaker margins. Goldman sees Intrepid Potash’s valuation as stretched and continues to have a $29 price target on the stock.

Advanced Energy AEIS was downgraded to sell from buy at ThinkEquity on disappointing third-quarter results and guidance. The price target was lowered to $7 from $14.

Health Net HNT was downgraded to neutral from buy at Goldman on concerns over the regulatory and pricing environment in California. the price target was lowered to $29 from $32.

Goldman also downgraded Community Health CYH to sell from neutral on concern about the overhangs from government investigations. The price target was lowered to $17 from $19.

Goldman raised its estimates and price target for MasterCard MA on a better-than-expected third quarter report. The new price target is $400, up from $380. The shares are rated a buy.

Story Conversation

About The Tell

The Tell is MarketWatch’s fast and engaging look at trends and themes in the day’s markets. Drawing on our reporters, analysts and commentators around the world, as well as selecting the best of the rest online, The Tell is all about the pulse of the markets through news, insight and strategic information to help you make the best investing decisions. Got a tip? Tell us at TheTell@MarketWatch.com